Conversion from failed antireflux surgery to RefluxStop: A multicenter feasibility, technical evaluation, safety, and effectiveness study with 30 consecutive cases

• by Thorsten G. Lehmann, Joerg Zehetner

• June 11, 2026

FDA Expands Bladder Cancer Regimen

KEYNOTE-B15/EV-304 demonstrated statistically significant improvements in event-free and overall survival with perioperative pembrolizumab plus enfortumab vedotin-ejfv compared with neoadjuvant gemcitabine plus cisplatin.

• by Kathryn Wighton

• July 10, 2026

• 2 min

Intraoperative hypothermia risk trajectories in patients undergoing video-assisted thoracoscopic surgery: a retrospective study

• by Rui Chen, Xiaomin Ma, Sha Luo, Jing Li, Liwen Xu

• July 13, 2026

Machine learning-based prediction models for postoperative pulmonary complications in elderly patients undergoing abdominal surgery

• by Qiang Zhong, Guiming Huang, Wen Zhou, Baolin Zhong, Yijian Chen, Jiegang Zhou, Junjun Li

• July 14, 2026